封面
市場調查報告書
商品編碼
1447618

花生四烯酸市場規模 - 按形式(固體和溶劑)按來源(植物和動物)按應用(嬰兒配方奶粉和補充劑)和預測,2024 - 2032 年

Arachidonic Acid Market Size - By Form (Solid, & Solvent) By Source (Plant, & Animal) By Application (Infant Formula, & Supplement), & Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 300 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於消費者對必需脂肪酸在維持整體健康和福祉方面的重要性的認知不斷提高,預計 2024 年至 2032 年花生四烯酸市場規模的CAGR將超過 3.9%。

根據疾病預防控制中心和美國農業部的數據,十分之九的美國人患有鉀缺乏症。隨著全球消費者健康意識的不斷增強,對含有花生四烯酸的膳食補充劑的需求激增,特別是在膳食缺乏症普遍存在的地區。此外,嬰兒配方奶粉和功能性食品中擴大採用花生四烯酸,也有助於市場成長。

整個花生四烯酸市場根據形式、應用和地區進行分類。

由於其在藥品、化妝品和動物飼料等各個行業的廣泛應用,預計到 2032 年,溶劑型細分市場將在市場上產生大量收入。溶劑形式的花生四烯酸用作生產抗發炎藥物、護膚配方和動物飼料添加劑的關鍵成分。其多功能性和有效性有利於產品的採用。

由於越來越多的消費者將花生四烯酸補充劑涵蓋其日常飲食方案,預計到 2032 年,補充劑應用領域將大幅成長。隨著飲食偏好轉向功能性食品和營養補充劑,製造商正在利用這一趨勢,提供各種針對各種健康益處的富含花生四烯酸的產品。此外,生活方式相關疾病的日益普及和人口老化正在推動對旨在促進心血管健康、認知功能和整體健康的補充劑的需求。

在完善的製藥和食品行業以及支持花生四烯酸在膳食補充劑和嬰兒配方奶粉中使用的有利監管框架的推動下,到 2032 年,歐洲花生四烯酸行業規模將顯著擴大。此外,旨在探索花生四烯酸治療潛力的研發活動的投資不斷增加,進一步推動了該地區的市場成長。隨著消費者意識的不斷增強和飲食模式的不斷變化,歐洲對於花生四烯酸製造商和供應商來說仍然是一個利潤豐厚的市場。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:花生四烯酸產業洞察

  • 產業生態系統分析
  • 技術與創新格局
  • 監管環境
  • 產業影響力
    • 成長動力
    • 產業陷阱與挑戰
  • 成長潛力分析
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章:市場估計與預測:按表格,2018-2032 年

  • 主要趨勢
  • 堅硬的
  • 溶劑

第 6 章:市場估計與預測:依來源分類,2018-2032 年

  • 主要趨勢
  • 植物
  • 動物

第 7 章:市場估計與預測:按應用2018-2032

  • 主要趨勢
  • 嬰幼兒配方奶粉
  • 補充
  • 其他

第 8 章:市場估計與預測:按地區,2018-2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 馬來西亞
    • 印尼
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第 9 章:公司簡介

  • BASF SE
  • Beijing Gingko Group (BGG)
  • Cargill, Incorporated
  • Cayman Chemical
  • Croda International Plc
  • DSM Nutritional Products
  • Enzymotec (Acquired by Frutarom)
  • Jarrow Formulas
  • Kingdomway Nutrition Inc.
  • Lallemand Health Solutions
  • Lipoid GmbH
  • Martek Biosciences Corporation (now part of DSM)
  • Suntory Holdings Limited
  • Xiamen Kingdomway Group Company
  • Zhejiang Medicine Co., Ltd.
簡介目錄
Product Code: 7967

Arachidonic acid market size is anticipated to record more than 3.9% CAGR from 2024 to 2032 owing to the rising consumer awareness regarding the importance of essential fatty acids in maintaining overall health and well-being.

As per the CDC and the USDA, 9 out of 10 Americans have a potassium deficiency. With growing health consciousness among consumers worldwide, there has been a surge in demand for dietary supplements containing arachidonic acid, particularly in regions where dietary deficiencies are prevalent. Additionally, the increasing adoption of arachidonic acid in infant formula and functional food products contributes to market growth.

The overall arachidonic acid market is classified based on form, application, and region.

The solvent form segment is predicted to generate massive revenue in the market by 2032 owing to its wide-ranging applications across various industries such as pharmaceuticals, cosmetics, and animal feed. Arachidonic acid in solvent form is used as a key ingredient in the production of anti-inflammatory drugs, skin care formulations, and animal feed additives. Its versatility and effectiveness are favoring the product adoption.

The supplement application segment is expected to witness substantial growth through 2032 owing to an increasing number of consumers incorporating arachidonic acid supplements into their daily dietary regimes. As dietary preferences shift towards functional foods and nutritional supplements, manufacturers are capitalizing on this trend by offering a diverse range of arachidonic acid-enriched products targeting various health benefits. Moreover, the growing prevalence of lifestyle-related disorders and the aging population are driving the demand for supplements aimed at promoting cardiovascular health, cognitive function, and overall wellness.

Europe arachidonic acid industry size will expand significantly through 2032, propelled by the p well-established pharmaceutical and food sectors, coupled with favorable regulatory frameworks supporting the use of arachidonic acid in dietary supplements and infant formula. Additionally, increasing investments in R&D activities aimed at exploring the therapeutic potential of arachidonic acid are further driving market growth in the region. With growing consumer awareness and evolving dietary patterns, Europ remains a lucrative market for arachidonic acid manufacturers and suppliers.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Market 360 degree synopsis

Chapter 3 Arachidonic Acid Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Technology & innovation landscape
  • 3.3 Regulatory landscape
  • 3.4 Industry impact forces
    • 3.4.1 Growth drivers
    • 3.4.2 Industry pitfalls & challenges
  • 3.5 Growth potential analysis
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Company market share analysis
  • 4.2 Competitive positioning matrix
  • 4.3 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Form, 2018-2032 (USD Million, Kilo Tons)

  • 5.1 Key trends
  • 5.2 Solid
  • 5.3 Solvent

Chapter 6 Market Estimates & Forecast, By Source, 2018-2032 (USD Million, Kilo Tons)

  • 6.1 Key trends
  • 6.2 Plant
  • 6.3 Animal

Chapter 7 Market Estimates & Forecast, By Application 2018-2032 (USD Million, Kilo Tons)

  • 7.1 Key trends
  • 7.2 Infant formula
  • 7.3 Supplement
  • 7.4 Others

Chapter 8 Market Estimates & Forecast, By Region, 2018-2032 (USD Million, Kilo Tons)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 UK
    • 8.3.2 Germany
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Russia
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 South Korea
    • 8.4.5 Australia
    • 8.4.6 Malaysia
    • 8.4.7 Indonesia
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 MEA
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 South Africa

Chapter 9 Company Profiles

  • 9.1 BASF SE
  • 9.2 Beijing Gingko Group (BGG)
  • 9.3 Cargill, Incorporated
  • 9.4 Cayman Chemical
  • 9.5 Croda International Plc
  • 9.6 DSM Nutritional Products
  • 9.7 Enzymotec (Acquired by Frutarom)
  • 9.8 Jarrow Formulas
  • 9.9 Kingdomway Nutrition Inc.
  • 9.10 Lallemand Health Solutions
  • 9.11 Lipoid GmbH
  • 9.12 Martek Biosciences Corporation (now part of DSM)
  • 9.13 Suntory Holdings Limited
  • 9.14 Xiamen Kingdomway Group Company
  • 9.15 Zhejiang Medicine Co., Ltd.